 Proarrhythmia cardiac arrest death young patients encainide flecainide Pediatric Electrophysiology Group potential proarrhythmic responses class IC sodium channel-blocking drugs young patients data institutions young patients treatment supraventricular tachycardias encainide patients patients ventricular arrhythmias encainide patients patients frequency proarrhythmia cardiac arrest death therapy adverse events drugs similar regard efficacy flecainide rate proarrhythmic responses patients experienced cardiac arrest encainide treatment encainide data patients adverse events Patient age previous drug trials concomitant therapy days inpatient monitoring similar patients encainide flecainide echocardiographic ventricular shortening treatment patients encainide flecainide Plasma drug concentrations Cardiac arrest patients deaths patients patients underlying heart disease patients flecainide supraventricular tachycardia Fifteen patients normal heart normal ventricular function proarrhythmia treatment supraventricular tachycardia cardiac arrest high incidence adverse events treatment encainide flecainide patients underlying heart disease